Barclays PLC Immutep LTD Transaction History
Barclays PLC
- $377 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding IMMP
# of Institutions
31Shares Held
1.86MCall Options Held
264KPut Options Held
90.5K-
Black Rock Inc. New York, NY839KShares$1.7 Million0.0% of portfolio
-
Meridian Wealth Management, LLC398KShares$808,8530.04% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA113KShares$228,3810.0% of portfolio
-
Xy Capital LTD Central, K3108KShares$219,9480.08% of portfolio
-
Jane Street Group, LLC New York, NY80.5KShares$163,3920.0% of portfolio
About IMMUTEP Ltd
- Ticker IMMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,000
- Market Cap $176M
- Description
- Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...